NCT01975961View on ClinicalTrials.gov

PK Study of Telmisartan/Rosuvastatin FDC Compared to Combination of Telmisartan and Rosuvastatin

PHASE1CompletedINTERVENTIONAL
Enrollment

185

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

August 31, 2013

Study Completion Date

September 30, 2013

Conditions
Dyslipidemia & Hypertension
Interventions
DRUG

Crestor 20mg(Rosuvastatin 20mg), Micardis 80mg(Telmisartan 80mg) , FDC

For co-administration, Crestor 1 tablet and Micardis 1 tablet. For FDC administration, FDC 1 tablet.

Trial Locations (1)

Unknown

Severance Hospital, Seoul

All Listed Sponsors
lead

Yuhan Corporation

INDUSTRY

NCT01975961 - PK Study of Telmisartan/Rosuvastatin FDC Compared to Combination of Telmisartan and Rosuvastatin | Biotech Hunter | Biotech Hunter